Düring, Joachim
Annborn, Martin
Cronberg, Tobias
Dankiewicz, Josef
Devaux, Yvan
Hassager, Christian
Horn, Janneke
Kjaergaard, Jesper
Kuiper, Michael
Nikoukhah, Homa Rafi
Stammet, Pascal
Undén, Johan
Wanscher, Michael Jaeger
Wise, Matt
Friberg, Hans
Nielsen, Niklas
Funding for this research was provided by:
Lundbeckfonden (R186-2015-2132)
Swedish Research Council (134281, 296161, 286321)
Swedish Heart Lung Foundation (20090275)
Arbetsmarknadens Försäkringsaktiebolag (100001)
Skåne University Hospital Foundations, the Gyllenstierna-Krapperup Foundation, and governmental funding of clinical research within the Swedish National Health System (M2010/1837, M2010/1641, 353301)
The County Council of Skåne (NA)
The Swedish Society of Medicine (NA)
The Koch Foundation (NA)
TrygFonden (NA)
European Clinical Research Infrastructures Network (NA)
Thelma Zoega Foundation (NA)
Stig and Ragna Gorthon Foundation (NA)
Thure Carlsson Foundation (NA)
Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research (NA)
Lions Research fund Skåne (NA)
South Swedish Hospital Region Research Funds (NA)
The Swedish Brain Foundation (NA)
The Torsten Söderberg foundation at the Royal Swedish Academy of Sciences (NA)
Article History
Received: 14 December 2019
Accepted: 16 April 2020
First Online: 28 April 2020
Ethics approval and consent to participate
: The TTM trial protocol was approved by ethical committees in each participating country, and informed consent was waived or obtained from all participants or relatives according to national legislations, in line with the Helsinki declaration. Ethical Review Board approval, REPN Lund Dnr 2009/324.
: Not applicable
: HF: Bard Medical (lecture fees), QuickCool (scientific advisor).HRN: Medical Director at Thermo Fisher Scientific.YD: Funds from; National Research Fund of Luxembourg (grants # C14/BM/8225223 and C17/BM/11613033), The Ministry of Higher Education and Research of Luxembourg and The Heart Foundation - Daniel Wagner.MW: BARD Medical (2009: Advisory board). BARD Medical (2018: Lecture, accommodation and travel fees).JK: Research on management of post cardiac arrest care supported by the NovoNordisk Foundation (NNF17OC0028706).